UP Health System - Marquette is an American hospital and regional medical center located in Marquette and serving the Upper Peninsula of Michigan. The hospital is a Level II trauma center as verified by the American College of Surgeons.

There are 307 beds in Marquette General Hospital.

During the past decade, Marquette General Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 36 clinical trials were completed, i.e. on average, 180% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 16 clinical trials were completed. i.e. 533.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marquette General Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 41 trials, followed by "National Cancer Institute (NCI)" with 19 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "Alliance for Clinical Trials in Oncology" with 9 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marquette General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "North Central Cancer Treatment Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Marquette General Hospital" are "Breast Cancer" (13 trials), "Head and Neck Cancer" (9 trials), "Lung Cancer" (9 trials), "Prostate Cancer" (9 trials) and "Metastatic Cancer" (6 trials). Many other conditions were trialed in "Marquette General Hospital" in a lesser frequency.

Most popular intervention types in "Marquette General Hospital" are "Drug" (73 trials), "Radiation" (43 trials), "Other" (35 trials), "Biological" (27 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (32 trials), "Laboratory Biomarker Analysis" (17 trials), "cisplatin" (11 trials), "conventional surgery" (10 trials) and "Quality-of-Life Assessment" (7 trials). Other intervention names were less common.

The vast majority of trials in "Marquette General Hospital" are 81 trials for "All" genders, 19 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Marquette General Hospital". undefined are not yet recruiting, 6 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Marquette General Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Marquette General Hospital, 8 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".